Fiber type specific expression of TNF-alpha, IL-6 and IL-18 in human skeletal muscles

Exercise Immunology Review

Volumn 11, Issue , 2005, Pages 53-63

  Plomgaard, Peter ^a   Penkowa, Milena ^b   Pedersen, Bente K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Inflammation; Muscle biopsy; Soleus; Triceps; Vastus

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CYTOLOGY; FAST MUSCLE FIBER; GENE EXPRESSION; HUMAN; MALE; METABOLISM; PATHOLOGY; SKELETAL MUSCLE; SLOW MUSCLE FIBER;

ADULT; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; ORGAN SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646347676     PISSN: 10775552     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Alexopoulou L, Pasparakis M and Kollias G. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur J Immunol 27: 2588-2592, 1997. (Pubitemid 27453848)
2. Balagopal P, Schimke JC, Ades P, Adey D and Nair KS. Age effect on transcript levels and synthesis rate of muscle MHC and response to resistance exercise. Am J Physiol Endocrinol Metab 280: E203-E208, 2001.
3. Banzet S, Koulmann N, Simler N, Birot O, Sanchez H, Chapot R, Peinnequin A and Bigard X. Fibre-type specificity of interleukin-6 gene transcription during muscle contraction in rat: association with calcineurin activity. J Physiol 566: 839-847, 2005. (Pubitemid 41122665)
4. Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 35: 609-616, 1975.
5. Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J and Rupprecht HJ. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106: 24-30, 2002. (Pubitemid 34747437)
6. De Bleecker JL, Meire VI, Declercq W and Van Aken EH. Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies. Neuromuscul Disord 9: 239-246, 1999. (Pubitemid 29287259)
7. Escobar-Morreale HF, Botella-Carretero JI, Villuendas G, Sancho J and San Millan JL. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J Clin Endocrinol Metab 89: 806-811, 2004. (Pubitemid 38269896)
8. Espat NJ, Copeland EM and Moldawer LL. Tumor necrosis factor and cachexia: a current perspective. Surg Oncol 3: 255-262, 1994.
9. Esposito K, Marfella R and Giugliano D. Plasma interleukin-18 concentrations are elevated in type 2 diabetes. Diabetes Care 27: 272, 2004. (Pubitemid 38196744)
10. Esposito K, Pontillo A, Ciotola M, Di Palo C, Grella E, Nicoletti G and Giugliano D. Weight loss reduces interleukin-18 levels in obese women. J Clin Endocrinol Metab 87: 3864-3866, 2002. (Pubitemid 34879540)
11. Febbraio MA and Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16: 1335-1347, 2002. (Pubitemid 34913306)
12. Feingold KR and Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes 41 Suppl 2: 97-101, 1992.
13. Finotto S, Siebler J, Hausding M, Schipp M, Wirtz S, Klein S, Protschka M, Doganci A, Lehr HA, Trautwein C, Khosravi-Far R, Strand D, Lohse A, Galle PR, Blessing M and Neurath MF. Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut 53: 392-400, 2004. (Pubitemid 38241337)
14. Fischer CP, Hiscock NJ, Penkowa M, Basu S, Vessby B, Kallner A, Sjoberg LB and Pedersen BK. Supplementation with vitamins C and E inhibits the release of interleukin- 6 from contracting human skeletal muscle. J Physiol 558: 633-645, 2004. (Pubitemid 39117607)
15. Fischer CP, Perstrup LB, Berntsen A, Eskildsen P and Pedersen BK. Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans. Clin Immunol 117: 152-160, 2005. (Pubitemid 41407725)
16. Greiwe JS, Cheng B, Rubin DC, Yarasheski KE and Semenkovich CF. Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J 15: 475-482, 2001. (Pubitemid 32141439)
17. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K and Scheurich P. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793-802, 1995.
18. Hamada K, Vannier E, Sacheck JM, Witsell AL and Roubenoff R. Senescence of human skeletal muscle impairs the local inflammatory cytokine response to acute eccentric exercise. FASEB J 19: 264-266, 2005. (Pubitemid 40189276)
19. Hiscock N, Chan MH, Bisucci T, Darby IA and Febbraio MA. Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity. FASEB J 18: 992-994, 2004. (Pubitemid 39561502)
20. Keller P, Keller C, Carey AL, Jauffred S, Fischer CP, Steensberg A and Pedersen BK. Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6. Biochem Biophys Res Commun 310: 550-554, 2003. (Pubitemid 37163699)
21. Li YP and Reid MB. Effect of tumor necrosis factor-alpha on skeletal muscle metabolism. Curr Opin Rheumatol 13: 483-487, 2001. (Pubitemid 33070964)
22. Lindegaard B, Hansen AB, Pilegaard H, Keller P, Gerstoft J and Pedersen BK. Adipose tissue expression of IL-18 and HIV-associated lipodystrophy. AIDS 18: 1956-1958, 2004. (Pubitemid 39313213)
23. Mhatre M, Floyd RA and Hensley K. Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: common links and potential therapeutic targets. J Alzheimers Dis 6: 147-157, 2004. (Pubitemid 38560250)
24. Mingrone G, Rosa G, Di Rocco P, Manco M, Capristo E, Castagneto M, Vettor R, Gasbarrini G and Greco AV. Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement. Int J Obes Relat Metab Disord 26: 1165-1172, 2002.
25. Mishima Y, Kuyama A, Tada A, Takahashi K, Ishioka T and Kibata M. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus. Diabetes Res Clin Pract 52: 119-123, 2001. (Pubitemid 32366481)
26. Moss ML and Lambert MH. Shedding of membrane proteins by ADAM family proteases. Essays Biochem 38: 141-153, 2002. (Pubitemid 36589200)
27. Oikawa Y, Shimada A, Kasuga A, Morimoto J, Osaki T, Tahara H, Miyazaki T, Tashiro F, Yamato E, Miyazaki J and Saruta T. Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice. J Immunol 171: 5865-5875, 2003. (Pubitemid 37467203)
28. Penkowa M, Keller C, Keller P, Jauffred S and Pedersen BK. Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise. FASEB J 17: 2166-2168, 2003.
29. Phillips T and Leeuwenburgh C. Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction. FASEB J 19: 668-670, 2005. (Pubitemid 40471280)
30. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR and Pedersen BK. Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54: 2939-2945, 2005. (Pubitemid 41401090)
31. Primeau AJ, Adhihetty PJ and Hood DA. Apoptosis in heart and skeletal muscle. Can J Appl Physiol 27: 349-395, 2002.
32. Reid MB, Lannergren J and Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med 166: 479-484, 2002.
33. Reid MB and Li YP. Cytokines and oxidative signalling in skeletal muscle. Acta Physiol Scand 171: 225-232, 2001. (Pubitemid 32823790)
34. Saghizadeh M, Ong JM, Garvey WT, Henry RR and Kern PA. The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest 97: 1111-1116, 1996. (Pubitemid 26070591)
35. Sasaki F, Shindoh C, Niwa T, Ohtaka T and Shindoh Y. Effects of interleukin-18 on diaphragm muscle contraction on rats. Tohoku J Exp Med 196: 269-280, 2002. (Pubitemid 34727563)
36. Starkie RL, Arkinstall MJ, Koukoulas I, Hawley JA and Febbraio MA. Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J Physiol 533: 585-591, 2001. (Pubitemid 32520010)
37. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B and Klarlund PB. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise- induced increase in plasma interleukin-6. J Physiol 529 Pt 1: 237-242, 2000.
38. van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Moller K, Saltin B, Febbraio MA and Pedersen BK. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88: 3005-3010, 2003. (Pubitemid 36877463)
39. Winkler G, Salamon F, Harmos G, Salamon D, Speer G, Szekeres O, Hajos P, Kovacs M, Simon K and Cseh K. Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity. Diabetes Res Clin Pract 42: 169-174, 1998. (Pubitemid 29009777)